RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc. (RAPT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · RAPT · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
RAPT Therapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
RAPT insider buying and selling by quarter
RAPT insider selling · RAPT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · RAPT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
RAPT executive sell shares · RAPT board member insider trading · RAPT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 3, 2026 | Lyons-Williams Lori Director | Other | 4,956 | — | Form 4 |
| Mar 3, 2026 | GRAY MARY ANN Director | Other | 4,956 | — | Form 4 |
| Mar 3, 2026 | Giordano Michael F Director | Other | 4,956 | — | Form 4 |
| Mar 3, 2026 | Dombkowski Ashley L. Director | Other | 4,956 | — | Form 4 |
| Mar 3, 2026 | Young Rodney KB CHIEF FINANCIAL OFFICER | Other | 3,304 | — | Form 4 |
| Mar 3, 2026 | Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICER | Other | 4,648 | — | Form 4 |
| Mar 3, 2026 | Wong Brian Russell PRESIDENT AND CEO · Director | Other | 64,102 | — | Form 4 |
| Mar 3, 2026 | Kozick Linda Director | Other | 4,956 | — | Form 4 |
| Mar 3, 2026 | Braunstein Scott Director | Other | 4,956 | — | Form 4 |
| Jan 30, 2026 | Braunstein Scott Director | Award | 4,956 | — | Form 4 |
| Jan 30, 2026 | Giordano Michael F Director | Award | 4,956 | — | Form 4 |
| Jan 30, 2026 | GRAY MARY ANN Director | Award | 4,956 | — | Form 4 |
| Jan 30, 2026 | Lyons-Williams Lori Director | Award | 4,956 | — | Form 4 |
| Jan 30, 2026 | Kozick Linda Director | Award | 4,956 | — | Form 4 |
| Jan 30, 2026 | Dombkowski Ashley L. Director | Award | 4,956 | — | Form 4 |
| Dec 23, 2024 | COLUMN GROUP II, LP 10% Owner | Other | 1,352,008 | $135 | Form 4 |
| Dec 23, 2024 | COLUMN GROUP II, LP 10% Owner | Other | 1,599,417 | $160 | Form 4 |
Brockstedt Dirk G.
CHIEF SCIENTIFIC OFFICER
Date
Mar 3
Shares
4,648
Price
—
Value
—
Wong Brian Russell
PRESIDENT AND CEO · Director
Date
Mar 3
Shares
64,102
Price
—
Value
—
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About RAPT insider trading
RAPT insider trades
RAPT Therapeutics, Inc. (RAPT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Lyons-Williams Lori (Director), GRAY MARY ANN (Director), Giordano Michael F (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. RAPT insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For RAPT Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
RAPT insider trading · 5 questionsThe insiders of RAPT Therapeutics, Inc. (RAPT) include executives and directors such as Lyons-Williams Lori (Director), GRAY MARY ANN (Director), Giordano Michael F (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026